NHS National Framework Agreement for Adalimumab Injection
Awarded by NHS England · to Amgen Ltd. · 2020-03-06T00:00:00Z · £445,000,000
Description
NHS Framework Agreement for Adalimumab Injection Offer reference number: CM/PHR/19/5575 Period of Framework Agreement: 1 April 2020 - 31 March 2022 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
- Supplier
- Amgen Ltd.
- Buyer
- NHS England
- Value
- £445,000,000
- Category (CPV)
- Pharmaceutical products
- Award date
- 2020-03-06T00:00:00Z
- Buyer constituency
- runcorn-and-helsby
Full CPV hierarchy, related awards from the same supplier and buyer, and any declared MP interest overlaps load below when JavaScript is enabled.